A innovative medication, this compound, is sparking significant attention within the medical community as a potential solution for obesity . Designed by researchers, it’s a twin GIP and GLP-1 receptor agonist, meaning it works on two distinct pathways to control hunger and support energy utilization. Early clinical results have indicated substant